PLNTQ yields 2000000.00% · JNJ yields 2.13%● Live data
📍 PLNTQ pulled ahead of the other in Year 1
Combined, PLNTQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PLNTQ + JNJ for your $10,000?
Proliance International, Inc. designs, manufactures, and markets heat exchange products and temperature control parts for the automotive and light truck aftermarket, as well as heat exchange products. The company's heat exchange products include radiators, heater cores, heaters, radiator cores, and condensers; and temperature control parts comprise condensers, compressors, accumulators/driers, and evaporators. It also offers air conditioning parts and supplies, such as hose and tube assemblies, expansion valves, blowers, and fan clutches. In addition, the company provides charge air coolers, oil coolers, marine coolers, and other specialty heat exchangers for heavy-duty trucks, buses, specialty equipment, and industrial and marine applications, such as agricultural, construction and military vehicles, oil rigs, stationary power generation equipment, and inland sea-going vessels. Its customers include national retailers of aftermarket automotive products, warehouse distributors, radiator shops, hard parts jobbers, and other manufacturers. The company offers its products in the United States, Canada, Mexico, Europe, and Central America. Proliance International, Inc. was formerly known as Transpro, Inc. and changed its name to Proliance International, Inc. in July 2005. The company was founded in 1915 and is based in New Haven, Connecticut.
Full PLNTQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.